#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Synovial sarcoma Gastric cancer Congenital myopathy Bronchiolitis Oesophageal achalasia Epstein-Barr virus infection Duchenne muscular dystrophy gene carrier Partial lipodystrophy Phaeochromocytoma Acute myeloid leukaemia (in remission) Neuropathic arthropathy Chronic lymphocytic leukaemia Ovarian cancer Langerhans' cell histiocytosis More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Basic Information Systemic sclerosis pulmonary – Life with Disease Short-bowel syndrome – Basic Information Short-bowel syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Osteosarcoma metastatic – Treatment Amyotrophic lateral sclerosis – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Trials in Disease Andersen-Tawil syndrome – Trials in Disease Erdheim-Chester disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibuprofen Arginine Mirabegron Bms-986442 Arachis Hypogaea Flour Osilodrostat Staphylococcus Aureus Potassium Chloride Inebilizumab Avalotcagene Ontaparvovec OXYBUTYNIN HYDROCHLORIDE SC0062 RUBIDIUM CHLORIDE Betula Pollen Extract Rasagiline Bdc-1001 Oditrasertib Imetelstat Sodium Clotrimazole Morphine Sulfate Glibenclamide More therapies…

    Learn about Your Condition

    Pneumococcal infection Kaposi's sarcoma Fracture infection Schizophreniform disorder HER2 positive breast cancer Mantle cell lymphoma Colonoscopy Anal cancer stage III Lupus nephritis Arthritis infective Acquired haemophilia Latent tuberculosis Aortic disorder Axial spondyloarthritis Thyroid disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Belantamab Mafodotin
    • Bortezomib
    Belgium Czechia France Germany Greece Italy +3

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    • Zanidatamab
    Belgium France Germany Italy Spain

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Salbutamol
    • Glycopyrronium Bromide
    • Budesonide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Andersen-Tawil syndrome
    • Arrhythmia
    Investigated Drugs:
    • Atenolol
    • Bisoprolol Fumarate
    • Chlortalidone
    The Netherlands

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Thrombocytopenia
    Investigated Drugs:
    • Netupitant
    • Pacritinib
    • Aprepitant
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Efavirenz for Patients with Early Alzheimer’s Disease

    Recruiting

    1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Efavirenz
    The Netherlands
Previous Page
1 … 499 500 501 502 503 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!